Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Application of novel catalysts: general discussion.
Miller AL, Bowker M, García-Trenco A, Socci J, Richards N, Hutchings G, Collis N, Earley J, Freakley S, Burch R, Howard M, Gross E, Kotarba A, Landau MV, Anderson J, Weckhuysen B, Kondrat S, Naranov E, Douthwaite JM, Tiruvalam R, Iqbal S, Parker L, Shah P, Nowicka E, Ueda W, Piovano A, Landon P, Fischer N, Reece C, Gates B, Lamb M, Jackman E, Jakubek T, Corma A, Claeys M, Svengren H, Friend C, Lennon D, Makepeace J, Hunter H, Manyar H. Miller AL, et al. Among authors: hunter h. Faraday Discuss. 2016 Jul 4;188:399-426. doi: 10.1039/C6FD90018F. Faraday Discuss. 2016. PMID: 27328423 No abstract available.
Hydrogen production from ammonia using sodium amide.
David WI, Makepeace JW, Callear SK, Hunter HM, Taylor JD, Wood TJ, Jones MO. David WI, et al. J Am Chem Soc. 2014 Sep 24;136(38):13082-5. doi: 10.1021/ja5042836. Epub 2014 Jun 22. J Am Chem Soc. 2014. PMID: 24972299 Free article.
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
Brittain G, Petrie J, Duffy KEM, Glover R, Hullock K, Papaioannou D, Roldan E, Beecher C, Bursnall M, Ciccarelli O, Coles AJ, Cooper C, Giovannoni G, Gabriel I, Kazmi M, Kyriakou C, Nicholas R, Paling D, Peniket A, Scolding N, Silber E, de Silva T, Venneri A, Walters SJ, Young C, Muraro PA, Sharrack B, Snowden JA; StarMS trial team. Brittain G, et al. BMJ Open. 2024 Feb 5;14(2):e083582. doi: 10.1136/bmjopen-2023-083582. BMJ Open. 2024. PMID: 38316583 Free PMC article.
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, Knapper S, Batten LM, Canham J, Hinson EL, Betteridge S, Overgaard UM, Gilkes A, Potter N, Mehta P, Kottaridis P, Cavenagh J, Hemmaway C, Arnold C, Freeman SD, Dennis M; PORTEC Study Group. Russell NH, et al. J Clin Oncol. 2024 Apr 1;42(10):1158-1168. doi: 10.1200/JCO.23.00943. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215358 Clinical Trial.
337 results